France Blood Glucose Monitoring Devices Market Insight
Published: 23 July 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The France blood glucose monitoring devices market is expected to experience an increase at a rate of 7.75% owing to high adoption rates of continuous glucose monitoring systems, increased need for non-invasive diabetes management tools, growth in investment for digital healthcare infrastructure and remote patient monitoring services.
France Blood Glucose Monitoring Devices Market Insights Forecasts to 2035
- The France Blood Glucose Monitoring Devices Market Size Was Estimated USD 785.4 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.75% from 2025 to 2035
- The France Blood Glucose Monitoring Devices Market Size is Expected to rise around USD 1,656.8 Million by 2035
Notable Insights for the France Blood Glucose Monitoring Devices Market
- The product-based segmentation indicates that the Continuous Glucose Monitoring (CGM) Systems & Smart Wearable Sensors segment holds a commanding position with almost 56% market share in the France Blood Glucose Monitoring Devices Market in 2025 due to its growing usage in type 1 diabetes management, automated insulin delivery integration, and real-time glycemic tracking.
- The application-based segmentation shows that the Hospitals, Clinics & Home Care Settings segment dominates with a market share of almost 63% in the France Blood Glucose Monitoring Devices Market in 2025 as a result of increased use of connected healthcare platforms and personal digital health applications.
- The global revenue for F. Hoffmann-La Roche Ltd. in fiscal year 2025 was estimated at about $72.4 billion, driven by rising demand for diabetes care solutions, diagnostic equipment, and personalized healthcare technologies.
- As per expectations, rising telehealth adoption trends and AI-driven glucose forecasting along with national health reimbursement policy support will drive market expansion in which continuous glucose monitoring technology increases glycemic control accuracy up to 41% and reduces severe hypoglycemic events up to 33%.
Download the eBook (ToC)
Research Methodologies Used to Analyze the France Blood Glucose Monitoring Devices Market
The France blood glucose monitoring devices market is analyzed by a blend of primary and secondary research approaches for ensuring accurate information about the market and its forecasted performance. Primary research is conducted through discussions with medical device manufacturers and distributors, clinical research centers, endocrinologists, hospital procurement heads, and experts to analyze demand trends, technological progress, and competitive activities. Secondary research will involve analyzing reports published by companies and governments, industry journals, scientific papers, import-export data, and industry organizations in connection with medical equipment and digital health industries. Market estimation, trend analysis, and forecasting methods will be used for estimating market size, growth opportunities, price dynamics, and investments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Blood Glucose Monitoring Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Blood Glucose Monitoring Devices Market
- Abbott Laboratories
- DexCom, Inc.
- F. Hoffmann-La Roche Ltd.
- Ascensia Diabetes Care Holdings AG
- Medtronic plc
- Lifescan, Inc.
- Terumo Corporation
- Ypsomed AG
- Senseonics Holdings, Inc.
- Nipro Corporation
Recent Developments:
- In January 2026, Abbott Laboratories entered into a strategic partnership with a major French digital healthcare consortium to integrate continuous glucose monitoring data with cloud-based hospital patient management systems.
- In August 2025, DexCom, Inc. introduced next-generation wearable glucose sensor systems featuring extended wear duration and real-time smartphone connectivity tailored for pediatric and adult diabetes care.
Market Segmentation:
France Blood Glucose Monitoring Devices Market, By Product Type
- Continuous Glucose Monitoring (CGM) Systems
- Self-Monitoring Blood Glucose (SMBG) Systems
- Blood Glucose Meters
- Testing Strips & Lancets
France Blood Glucose Monitoring Devices Market, By Technology
- Electrochemical Sensor Technologies
- Optical & Non-Invasive Sensing Platforms
- Bluetooth & Cloud-Connected Glucose Readers
France Blood Glucose Monitoring Devices Market, By Application
- Type 1 Diabetes Management
- Type 2 Diabetes Management
- Gestational Diabetes Monitoring
France Blood Glucose Monitoring Devices Market, By End-User
- Hospitals & Specialty Clinics
- Home Care Settings
- Diagnostic Centers
Expert Views:
The growth of blood glucose monitoring devices markets in France will be facilitated by increased use of advanced wearable diagnostic instruments, increasing number of diabetes healthcare programs, and higher demand for continuous real-time glycemic tracking techniques. The use of cloud-integrated analytics platforms, automated insulin pump synchronization, and non-invasive sensor materials will contribute to improved patient compliance and enhanced demand in hospital diagnostics, clinical management, home healthcare, and diabetes care markets in France.
Author: Govind and Krishna By Decisions Advisors and Consulting